May 22, 2025 3:40 am
Published by Diana Dugas
Professional Background: Yanling is a technical leader with strong expertise in biopharmecautical product development and manufacturing. She was initially trained as an applied chemist in China and later obtained her Master and PhD degrees in Physical Biochemistry in the UK. Prior to moving to Australia in 2009, she was a Senior Scientist in Bioprocess Development at MedImmune Cambridge UK (now AstraZeneca) leading antibody characterisation and formulation development. In the last 18 years, Yanling has led R&D teams in the biotech sector across UK,... Read More
October 8, 2024 10:17 pm
Published by Diana Dugas
Professional Background: Since joining ANSTO in 2000 as a postdoctoral research fellow, Ivan has been a key player in the field of radiochemistry. His expertise lies in the development of diagnostic radiopharmaceuticals using F-18, Tc-99m, and I-123 radioisotopes. In 2003, he was appointed as a Radiochemist and, in 2010, he took on the role of Head of Radiochemistry. In this capacity, Ivan has successfully managed a team of radioisotope and radiopharmaceutical scientists, overseeing the delivery of technologies and products to... Read More
August 6, 2024 12:12 am
Published by Diana Dugas
Professional Background: Diana graduated from Rice University in 2007 with a PhD in Biochemistry and Cell Biology, focusing on plant genetics and microRNAs. She spent several years working as a bioinformatician before transitioning to a facilitator position, supporting communication and understanding between researchers and IT. Diana then became the Director for Instruction and Research Support at New Mexico State University, USA. Since moving to Australia, she has become the Centre Manager for DART. Research Interests: Although Diana is currently not... Read More
August 5, 2024 5:50 am
Published by Diana Dugas
Professional Background: Sam Graf is Head of Innovation and Partnerships at Cyclotek. Following the completion of his Master of Science at the University of Melbourne, Sam worked at the Peter MacCallum Cancer Centre as a Clinical Trial Coordinator. In 2022, Sam joined the team at Cyclotek to manage Cyclotek’s R&D projects and industry-academia collaborations. Research Interests: Sam completed his Master of Science under Professor Paul Donnelly at the University of Melbourne. There, his research focused on the synthesis and characterisation... Read More
August 5, 2024 5:49 am
Published by ntechmedia
Professional Background: Phil completed his PhD at the University of Strathclyde, in Glasgow and joined Monash as a Research Fellow in 1995 and was subsequently successful in being awarded a five-year ARC QEII Fellowship in 1997. He was appointed as a lecturer in the School in 2004. Prior to joining Monash Professor Andrews was an Alexander von Humboldt Fellow, at the Philipps Universität, Marburg, Germany, and he held a Royal Society Fellowship, at Griffith University in Queensland. The highly esteemed... Read More
August 5, 2024 5:40 am
Published by ntechmedia
Professional Background: Professor Donnelly leads a research group that is based in the School of Chemistry and Bio21 Molecular Science and Biotechnology Institute. Research Interests: Professor Donnelly is a chemist with expertise in inorganic chemistry, synthetic chemistry, radiochemistry and biological chemistry. Aspects of his research centre on the design and synthesis of new metal compounds for application in biology. Donnelly Research Group Website
August 5, 2024 5:26 am
Published by ntechmedia
Professional Background: Prof. Louis M. Rendina is a Professor of Chemistry and Associate Head of Research Education at The University of Sydney, Fellow of the Royal Australian Chemical Institute (RACI), Fellow of the Royal Society of NSW, and Fellow of the Royal Society of Chemistry (UK). He is also a Deputy Director and Node Leader of the ARC Development of Advanced Radiochemical Technologies (DART) Industrial Transformation Training Centre. Lou has an international reputation for original, impactful research and sustained excellence... Read More
August 5, 2024 4:58 am
Published by Diana Dugas
Professional Background: Univ.-Prof. Dr. Klaus Kopka (HZDR, Germany) is a radiopharmaceutical chemist and holds a full professorship (W3) for Bioinorganic and Radiopharmaceutical Chemistry at Technical University Dresden, Germany, which is combined with the directorship of the Institute of Radiopharmaceutical Cancer Research at Helmholtz-Zentrum Dresden-Rossendorf [HZDR]. Between 2013 and 2019 he held a W3 position at Ruprecht-Karls-University of Heidelberg, Germany. At the same time he was head of the Division of Radiopharmaceutical Chemistry at the German Cancer Research Center [DKFZ] in... Read More
